An independent NICE committee has recommended five devices to diagnose and assess the severity of obstructive sleep apnoea hypopnoea syndrome (OSAHS).
Around five per cent of the UK population are believed to live undiagnosed with the condition, which is associated with serious health problems including hypertension, diabetes, stroke and heart disease that can shorten life expectancy.
The new devices recommended by NICE in draft diagnostics guidance can be used at home while sleeping, do not require cannulas inserted into the nose, or formal instructions in hospital to use. They are considered less invasive, more comfortable to wear and easier to use…
